Nine treatments of 1000 mL therapeutic phlebotomy in a subject with polycythemia: A case report
Physiological ReportsLarge‐volume therapeutic phlebotomy is the mainstay of hemochromatosis treatment and offers an opportunity to investigate the hemodynamic changes during acute hypovolemia. An otherwise healthy 64‐year‐old male with hemochromatosis participated.
William J. Morton +5 more
doaj +3 more sources
Advances in polycythemia vera treatment with targeted therapies and clinical trials [PDF]
Discover OncologyPolycythemia vera (PV) is a chronic myeloproliferative disorder characterized by excessive red blood cell production, leading to a heightened risk of thrombosis, hemorrhage, and progression to myelofibrosis. While traditional therapies such as phlebotomy
Doaa Hassanien +7 more
doaj +2 more sources
PB2505: THERAPEUTIC PHLEBOTOMY INSTANTLY AFFECTS BLOOD PARAMETERS AND VISCOCITY IN SICKLE CELL DISEASE PATIENTS [PDF]
HemaSphere, 2023 Amna Jebali +5 more
doaj +2 more sources
Hemoglobin suresnes combined with α0-thalassemia: Diagnostic challenges and insights from trio-based whole exome sequencing [PDF]
Annals of HematologyHemoglobin Suresnes (Hb Suresnes) is a rare hemoglobin variant caused by a substitution of arginine to histidine at position 141 (p.Arg142His) in the COOH terminus of the α-globin chain. This structural change alters the oxygen affinity of hemoglobin and
Hung-Lin Liu, Wan-Ting Huang
doaj +2 more sources
Serum Ferritin in Women With HFE p.C282Y Homozygosity: Positive Associations With Age, Live Births, Menopause, and Transferrin Saturation [PDF]
eJHaemBackground We sought to determine associations of serum ferritin (SF) with live birth numbers and other iron‐related variables in women with HFE p.C282Y (rs1800562) homozygosity. Methods We studied non‐pregnant, non‐Hispanic white women in post‐screening
James C. Barton +2 more
doaj +2 more sources
Tmprss6-ASO as a tool for the treatment of Polycythemia Vera mice
PLoS ONE, 2021 Polycythemia Vera (PV) is a chronic myeloproliferative neoplasm resulting from an acquired driver mutation in the JAK2 gene of hematopoietic stem and progenitor cells resulting in the overproduction of mature erythrocytes and abnormally high hematocrit ...
Carla Casu +10 more
doaj +3 more sources
Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosis. [PDF]
, 2017 We measured hair and plasma concentrations of isoniazid among sixteen children with tuberculosis who underwent personal or video-assisted directly observed therapy and thus had 100% adherence.
Bacchetti, Peter +16 more
core +15 more sources
Successful use of phlebotomy to treat severe secondary polycythemia due to chronic lung disease
Hematology Reports, 2021 Secondary polycythemia (SP) occurs as a result of increase erythropoietin levels most commonly as a result of tissue hypoxia. Symptoms such as erythromelalgia, pruritis, and bleeding, which are frequently seen in polycythemia vera (PV), do not commonly ...
Jacob Fuqua +2 more
doaj +1 more source
Therapeutic Phlebotomy for Testosterone-Induced Polycythemia [PDF]
American Journal of Clinical Pathology, 2020 Abstract Objectives To evaluate therapeutic phlebotomy (TP) requests for testosterone replacement therapy (TRT) and to highlight the impact to a blood center (BC) or service that provides TP for individuals on TRT.
Jed B Gorlin +3 more
openaire +2 more sources
Therapeutic Phlebotomy Revisited: A Review
Saudi Journal of Medicine, 2023 Therapeutic phlebotomy is the removal of red blood cells or serum iron from the blood. It is one of the preferred treatments for blood disorders. In ancient times this process was known as bloodletting. Generalized method included were venesection and arteriotomy and systemic methods included were cupping and by leeches.
Dr. Sharique Ahmad +2 more
openaire +1 more source